³ÉÈËVRÊÓÆµ

Insights

³ÉÈËVRÊÓÆµ Insights: Your source for healthcare news, ideas and analysis.

³ÉÈËVRÊÓÆµ Insights – including our new podcast – puts the vast depth of ³ÉÈËVRÊÓÆµâ€™s expertise at your fingertips, helping you stay informed about the latest healthcare trends and topics. Below, you can easily search based on your topic of interest to find useful information from our podcast, blogs, webinars, case studies, reports and more.

Show All | Podcast | Blogs | Webinars | Weekly Roundup | Videos | Case Studies | Reports | News | Spotlight

Filter by topic:

Receive timely expert insights on topics you care about.

Select Topics

68 Results found.

³ÉÈËVRÊÓÆµ News

³ÉÈËVRÊÓÆµ Launches Institute on Addiction

Read News

³ÉÈËVRÊÓÆµ (³ÉÈËVRÊÓÆµ) announced today creation of the ³ÉÈËVRÊÓÆµ Institute on Addiction (IOA), a division dedicated to supporting the national effort to build an evidence-based, patient-centered, and sustainable addiction treatment ecosystem.

Read More

Brief & Report

Three ³ÉÈËVRÊÓÆµ clinicians author naltrexone formulations in correctional settings issue brief

Download

³ÉÈËVRÊÓÆµâ€™s Donna Strugar-Fritsch, Shannon Robinson, MD and Scott Haga, PA-C, recently authored the issue brief, Naltrexone Formulations in Correctional Settings.  This brief provides clinical, financial, and administrative information prisons and jails can use in deciding whether to keep detainees on extended release naltrexone (XR-NTX, or the brand Vivitrol) or switch them to oral naltrexone tablets in instances where detainees have been prescribed XR-NXT prior to incarceration.

Blog

Early Bird Registration Expires July 29 for ³ÉÈËVRÊÓÆµ Conference, October 26-27 in Chicago

Read Blog

Be sure to register soon for ³ÉÈËVRÊÓÆµâ€™s conference on What’s Next for Medicaid, Medicare, and Publicly Sponsored Healthcare: How Payers, Providers, and States Are Navigating a Future of Opportunity and Uncertainty, October 26-27, at the Fairmont Chicago, Millennium Park. The Early Bird registration rate of $1595 per person expires on July 29.  After that, the rate is $1795.

Read More

Blog

³ÉÈËVRÊÓÆµ-developed medications for addiction treatment (MAT) training for justice and child welfare now available online

Read Blog

Focused on ongoing support and solutions for those living with opioid use disorder (OUD), ³ÉÈËVRÊÓÆµ (³ÉÈËVRÊÓÆµ) has developed a robust web-based training program about addiction and its treatment in the criminal justice and child welfare systems, including access to, and continued use of, medications for addiction treatment (MAT).

Read More

Blog

Webinar alert: Evidence-based treatment of opioid use disorder in correctional settings

Read Blog

³ÉÈËVRÊÓÆµ is cohosting a webinar with the

Opioid use disorder is a chronic brain disease with effective, evidence-based treatments, and is a condition protected by the Americans with Disabilities Act. Prisons and jails are expected, by national health care and justice organizations and by communities, to treat incarcerated persons with OUD in accordance with evidence-based practices. This webinar reviews the most current evidence-based care for opioid withdrawal and OUD treatment and provides clinicians with strategies to move correctional health practices into compliance with national and community standards.

Read More

Ready to talk?